We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4272:TSENippon Kayaku Co., Ltd. Analysis

Data as of 2026-06-12 - not real-time

¥2,090.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Current price of ¥2,090 sits just above the 20‑day SMA of ¥2,084.85 and comfortably above the 50‑day SMA, indicating a short‑term bullish bias, while the RSI of 58 suggests momentum is still intact. Support at ¥2,001 provides a cushion, but the MACD histogram is negative, signaling potential short‑term weakness. Volatility is elevated at 64% over the past 30 days, yet the beta is exceptionally low (~0.1), implying the stock moves largely independently of broader market swings. Fundamentally, revenue surged 23% YoY to ¥241.9 bn and profit margins hover around 10%, supporting a solid earnings base. The dividend yield of 3.22% with a payout ratio of ~41% appears sustainable given a healthy operating cash flow, despite a negative free‑cash‑flow figure. A DCF‑derived fair value of ¥4,551 suggests the market is pricing the stock at less than half of its intrinsic worth, pointing to a significant undervaluation. Given these dynamics, the stock presents a compelling blend of growth momentum, attractive yield, and upside potential, though investors should monitor the short‑term MACD signal and high volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near 20‑day SMA and support level
  • Bearish MACD histogram
  • Strong dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant undervaluation versus DCF fair value
  • Robust 23% revenue growth and healthy profit margins
  • Sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term upside to intrinsic value
  • Diversified chemicals and life‑sciences portfolio
  • Low beta and stable cash position relative to debt

Key Metrics & Analysis

Financial Health

Revenue Growth23.10%
Profit Margin10.19%
P/E Ratio13.0
ROE9.01%
ROA3.63%
Debt/Equity17.56
P/B Ratio1.1
Op. Cash Flow¥28.8B
Free Cash Flow¥-8271249920

Technical Analysis

TrendBullish
RSI58.2
Support¥2,001.00
Resistance¥2,192.50
MA 20¥2,084.85
MA 50¥1,915.60
MA 200¥1,692.91
MACDBearish
VolumeStable
Fear & Greed Index88.5

Valuation

Fair Value¥4,550.95
GradeUndervalued
TypeBlend
Dividend Yield3.22%

Risk Assessment

Beta0.10
Volatility64.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.